Ablatherm FDA Study in Triangle Business Journal

Home  /  Investors Information    /     /  Ablatherm FDA Study in Triangle Business Journal
Planet edap Inc.
Jul 27,2006
<< Back

Ablatherm FDA Study in Triangle Business Journal

Ablatherm FDA Study in Triangle Business JournalEDAP's Ablatherm-HIFU FDA clinical study was recently featured in the Triangle Business Journal. The article is viewable online at

http://triangle.bizjournals.com/triangle/stories/2006/07/17/focus4.html . 

A patient treated at Duke University Medical Center in quoted along with the urologist performing the procedure.

The patient, aged 57, was released 4 hours after his treatment start time as compared to a hospital stay of up to 7 days following surgery.

Dr. Cary Robertson of Duke University describes the procedure and references clinical evidence from Canada and Europe where HIFU has been fully approved for use in treating localized prostate cancer.